Literature DB >> 24920010

Disassociation of verbal learning and hippocampal volume in type 2 diabetes and major depression.

O Ajilore1, M Lamar, J Medina, K Watari, V Elderkin-Thompson, A Kumar.   

Abstract

OBJECTIVE: The purpose of this study was to examine the relationship between verbal learning and memory performance and hippocampal volume in subjects with co-morbid type 2 diabetes and major depression compared with healthy control subjects and subjects with type 2 diabetes alone.
METHODS: Twenty four subjects with type 2 diabetes and 20 subjects with type 2 diabetes and major depression were recruited from endocrinology clinics and were compared with 32 healthy control subjects recruited from the community. Subjects were scanned on a 1.5 T GE scanner, and hippocampal volumes were measured using Freesurfer. The California Verbal Learning Test assessed learning and memory. Significant predictors of verbal learning performance (e.g., age, gender, education, blood pressure, stroke risk, hemoglobin A1c, and hippocampal volume) were determined using a stepwise linear regression.
RESULTS: Subjects with diabetes and depression had significantly worse performance on verbal list learning compared with healthy control subjects. Hippocampal volume was a strong predictor of performance in healthy control subjects, and age and hippocampal volume were strong predictors in subjects with type 2 diabetes alone. Age alone was a significant predictor of verbal learning performance in subjects with diabetes and depression.
CONCLUSIONS: The relationship between hippocampal volume and performance on the California Verbal Learning Test is decoupled in subjects with type 2 diabetes and major depression and this decoupling may contribute to poor verbal learning and memory performance in this study population.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Diabetes; cognition; depression; hippocampus; medical co-morbidities

Mesh:

Year:  2014        PMID: 24920010      PMCID: PMC4264998          DOI: 10.1002/gps.4149

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  27 in total

1.  A rating scale for depression.

Authors:  M HAMILTON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1960-02       Impact factor: 10.154

Review 2.  The hippocampus and depression.

Authors:  Y I Sheline; B L Mittler; M A Mintun
Journal:  Eur Psychiatry       Date:  2002-07       Impact factor: 5.361

3.  Deficits in hippocampal and anterior cingulate functioning during verbal declarative memory encoding in midlife major depression.

Authors:  J Douglas Bremner; Meena Vythilingam; Eric Vermetten; Viola Vaccarino; Dennis S Charney
Journal:  Am J Psychiatry       Date:  2004-04       Impact factor: 18.112

4.  The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description.

Authors:  R L Spitzer; J B Williams; M Gibbon; M B First
Journal:  Arch Gen Psychiatry       Date:  1992-08

5.  Sequence-independent segmentation of magnetic resonance images.

Authors:  Bruce Fischl; David H Salat; André J W van der Kouwe; Nikos Makris; Florent Ségonne; Brian T Quinn; Anders M Dale
Journal:  Neuroimage       Date:  2004       Impact factor: 6.556

6.  The association of comorbid depression with mortality in patients with type 2 diabetes.

Authors:  Wayne J Katon; Carolyn Rutter; Greg Simon; Elizabeth H B Lin; Evette Ludman; Paul Ciechanowski; Leslie Kinder; Bessie Young; Michael Von Korff
Journal:  Diabetes Care       Date:  2005-11       Impact factor: 19.112

7.  Cognitive function in adults with type 2 diabetes and major depression.

Authors:  Kecia Watari; Andrea Letamendi; Virginia Elderkin-Thompson; Ebrahim Haroon; Jacqueline Miller; Christine Darwin; Anand Kumar
Journal:  Arch Clin Neuropsychol       Date:  2006-10-09       Impact factor: 2.813

8.  Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes.

Authors:  S M Gold; I Dziobek; V Sweat; A Tirsi; K Rogers; H Bruehl; W Tsui; S Richardson; E Javier; A Convit
Journal:  Diabetologia       Date:  2007-02-14       Impact factor: 10.122

Review 9.  Diagnosis and classification of diabetes mellitus: new criteria.

Authors:  J Mayfield
Journal:  Am Fam Physician       Date:  1998-10-15       Impact factor: 3.292

10.  Executive dysfunction and memory in older patients with major and minor depression.

Authors:  Virginia Elderkin-Thompson; Jim Mintz; Ebrahim Haroon; Helen Lavretsky; Anand Kumar
Journal:  Arch Clin Neuropsychol       Date:  2007-02       Impact factor: 2.813

View more
  4 in total

Review 1.  Diabetes, Depression, and Cognition: a Recursive Cycle of Cognitive Dysfunction and Glycemic Dysregulation.

Authors:  Sheila Black; Kyle Kraemer; Avani Shah; Gaynell Simpson; Forrest Scogin; Annie Smith
Journal:  Curr Diab Rep       Date:  2018-09-28       Impact factor: 4.810

2.  What Metabolic Syndrome Contributes to Brain Outcomes in African American & Caucasian Cohorts.

Authors:  Melissa Lamar; Leah H Rubin; Olusola Ajilore; Rebecca Charlton; Aifeng Zhang; Shaolin Yang; Jamie Cohen; Anand Kumar
Journal:  Curr Alzheimer Res       Date:  2015       Impact factor: 3.498

3.  Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report.

Authors:  Peter T Nelson; Dennis W Dickson; John Q Trojanowski; Clifford R Jack; Patricia A Boyle; Konstantinos Arfanakis; Rosa Rademakers; Irina Alafuzoff; Johannes Attems; Carol Brayne; Ian T S Coyle-Gilchrist; Helena C Chui; David W Fardo; Margaret E Flanagan; Glenda Halliday; Suvi R K Hokkanen; Sally Hunter; Gregory A Jicha; Yuriko Katsumata; Claudia H Kawas; C Dirk Keene; Gabor G Kovacs; Walter A Kukull; Allan I Levey; Nazanin Makkinejad; Thomas J Montine; Shigeo Murayama; Melissa E Murray; Sukriti Nag; Robert A Rissman; William W Seeley; Reisa A Sperling; Charles L White; Lei Yu; Julie A Schneider
Journal:  Brain       Date:  2019-06-01       Impact factor: 15.255

4.  Association between Type 2 Diabetes Mellitus and Brain Atrophy: A Meta-Analysis.

Authors:  Tianqi Zhang; Marnie Shaw; Nicolas Cherbuin
Journal:  Diabetes Metab J       Date:  2022-03-08       Impact factor: 5.893

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.